Technical Analysis for ACST - Acasti Pharma, Inc.

Grade Last Price % Change Price Change
grade D 1.08 -1.82% -0.02
ACST closed down 1.82 percent on Wednesday, April 18, 2018, on 62 percent of normal volume.
3 Watchers
Intraday Alerts Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical ACST trend table...

Date Alert Name Type % Chg
Apr 18 MACD Bearish Signal Line Cross Bearish 0.00%
Apr 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Apr 17 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.82%
Apr 17 Doji - Bullish? Reversal -1.82%
Apr 17 Outside Day Range Expansion -1.82%
Apr 17 Wide Bands Range Expansion -1.82%
Apr 16 1,2,3 Pullback Bullish Bullish Swing Setup -1.82%
Apr 16 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.82%
Apr 16 NR7 Range Contraction -1.82%
Apr 16 NR7-2 Range Contraction -1.82%

Older signals for ACST ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Is ACST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Apr 2 Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures
Mar 14 Acasti Pharma Announces First Patient Randomized in Pivotal TRILOGY Phase 3 Program of CaPre in Severe Hypertriglyceridemia
Feb 14 Acasti reports 4Q loss
Feb 13 Acasti Pharma reports Q3 results
Feb 13 Acasti Pharma Reports Third Quarter FY 2018 Financial Results
Jan 22 Acasti Pharma Announces the Closing of Over-Allotment Option for its Public Offering of Common Shares
Jan 16 Acasti Pharma Announces Change to Board of Directors
Jan 8 Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures
Jan 5 Premarket Gainers as of 9:05 am
Jan 4 Acasti Expands Global Patent Portfolio with Newly Granted Patents in South Korea and Canada
See more ACST news...
Indicators
Indicator Value
52 Week High 3.36
52 Week Low 0.84
Average Volume 186,035
200-Day Moving Average 1.2387
50-Day Moving Average 1.0378
20-Day Moving Average 1.0808
10-Day Moving Average 1.111
Average True Range 0.064
ADX 29.53
+DI 22.22
-DI 13.33
Chandelier Exit (Long, 3 ATRs ) 0.998
Chandelier Exit (Short, 3 ATRs ) 1.162
Upper Bollinger Band 1.1719
Lower Bollinger Band 0.9897
Percent B (%b) 0.5
BandWidth 16.857883
MACD Line 0.0207
MACD Signal Line 0.0225
MACD Histogram -0.0018
Fundamentals Value
Market Cap 15.89 Million
Num Shares 14.7 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -1.40
Price-to-Sales 0.00
Price-to-Book 1.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.14
Resistance 3 (R3) 1.14 1.13 1.13
Resistance 2 (R2) 1.13 1.11 1.13 1.13
Resistance 1 (R1) 1.10 1.10 1.10 1.10 1.12
Pivot Point 1.09 1.09 1.08 1.09 1.09
Support 1 (S1) 1.06 1.07 1.06 1.06 1.04
Support 2 (S2) 1.05 1.06 1.05 1.03
Support 3 (S3) 1.02 1.05 1.03
Support 4 (S4) 1.02